By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy
- Home
- Pharmaceuticals
- Report Detail
Global Intravenous (IV) Solution Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Intravenous (IV) Solution manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Intravenous (IV) Solution market. Further, it explains the major drivers and regional dynamics of the global Intravenous (IV) Solution market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
- ICU Medical
- B. Braun Melsungen
- Fresenius Kabi
- Baxter
- Amanta Healthcare
- Terumo Medical
- Grifols
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Intravenous (IV) Solution Segment by Type
- Total Parenteral Solution
- Peripheral Parenteral Solution
Intravenous (IV) Solution Segment by Application
- Hospitals & Clinics
- Ambulatory
- Homecare
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Intravenous (IV) Solution market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Intravenous (IV) Solution, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Intravenous (IV) Solution, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Intravenous (IV) Solution, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Intravenous (IV) Solution sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Intravenous (IV) Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Intravenous (IV) Solution sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including ICU Medical, B. Braun Melsungen, Fresenius Kabi, Baxter, Amanta Healthcare, Terumo Medical and Grifols, etc.
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Intravenous (IV) Solution Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Total Parenteral Solution
1.2.3 Peripheral Parenteral Solution
1.3 Market Segment by Application
1.3.1 Global Intravenous (IV) Solution Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals & Clinics
1.3.3 Ambulatory
1.3.4 Homecare
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Intravenous (IV) Solution Market Size (2017-2028)
2.1.1 Global Intravenous (IV) Solution Revenue (2017-2028)
2.1.2 Global Intravenous (IV) Solution Sales (2017-2028)
2.2 Global Intravenous (IV) Solution Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Intravenous (IV) Solution Sales by Regions (2017-2022)
2.2.2 Global Intravenous (IV) Solution Revenue by Regions (2017-2022)
2.3 Global Intravenous (IV) Solution Market Size Forecast by Region
2.3.1 Global Intravenous (IV) Solution Sales Forecast by Region (2023-2028)
2.3.2 Global Intravenous (IV) Solution Revenue Forecast by Region (2023-2028)
2.4 Global Top Intravenous (IV) Solution Regions (Countries) Ranking by Market Size
2.5 Intravenous (IV) Solution Market Dynamics
2.5.1 Intravenous (IV) Solution Market Trends
2.5.2 Intravenous (IV) Solution Market Drivers
2.5.3 Intravenous (IV) Solution Market Challenges
2.5.4 Intravenous (IV) Solution Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Intravenous (IV) Solution Manufacturers by Sales (2017-2022)
3.1.1 Global Intravenous (IV) Solution Sales by Manufacturers (2017-2022)
3.1.2 Global Intravenous (IV) Solution Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Intravenous (IV) Solution Sales in 2021
3.2 Global Top Manufacturers Intravenous (IV) Solution by Revenue
3.2.1 Global Intravenous (IV) Solution Revenue by Manufacturers (2017-2022)
3.2.2 Top Intravenous (IV) Solution Manufacturers Covered: Ranking by Revenue
3.2.3 Global Intravenous (IV) Solution Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Intravenous (IV) Solution Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous (IV) Solution as of 2021)
3.4 Global Intravenous (IV) Solution Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Intravenous (IV) Solution Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Intravenous (IV) Solution Market
3.7 Key Manufacturers Intravenous (IV) Solution Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Intravenous (IV) Solution Market Size by Type
4.1 Global Intravenous (IV) Solution Historic Market Review by Type (2017-2022)
4.1.1 Global Intravenous (IV) Solution Sales Market Share by Type (2017-2022)
4.1.2 Global Intravenous (IV) Solution Revenue Market Share by Type (2017-2022)
4.1.3 Intravenous (IV) Solution Price by Type (2017-2022)
4.2 Global Intravenous (IV) Solution Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Intravenous (IV) Solution Sales Forecast by Type (2023-2028)
4.2.2 Global Intravenous (IV) Solution Revenue Forecast by Type (2023-2028)
4.2.3 Intravenous (IV) Solution Price Forecast by Type (2023-2028)
5 Global Intravenous (IV) Solution Market Size by Application
5.1 Global Intravenous (IV) Solution Historic Market Review by Application (2017-2022)
5.1.1 Global Intravenous (IV) Solution Sales Market Share by Application (2017-2022)
5.1.2 Global Intravenous (IV) Solution Revenue Market Share by Application (2017-2022)
5.1.3 Intravenous (IV) Solution Price by Application (2017-2022)
5.2 Global Intravenous (IV) Solution Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Intravenous (IV) Solution Sales Forecast by Application (2023-2028)
5.2.2 Global Intravenous (IV) Solution Revenue Forecast by Application (2023-2028)
5.2.3 Intravenous (IV) Solution Price Forecast by Application (2023-2028)
6 North America
6.1 North America Intravenous (IV) Solution Sales Breakdown by Company
6.1.1 North America Intravenous (IV) Solution Sales by Company (2017-2022)
6.1.2 North America Intravenous (IV) Solution Revenue by Company (2017-2022)
6.2 North America Intravenous (IV) Solution Market Size by Type
6.2.1 North America Intravenous (IV) Solution Sales by Type (2017-2028)
6.2.2 North America Intravenous (IV) Solution Revenue by Type (2017-2028)
6.3 North America Intravenous (IV) Solution Market Size by Application
6.3.1 North America Intravenous (IV) Solution Sales by Application (2017-2028)
6.3.2 North America Intravenous (IV) Solution Revenue by Application (2017-2028)
6.4 North America Intravenous (IV) Solution Market Size by Country
6.4.1 North America Intravenous (IV) Solution Sales by Country (2017-2028)
6.4.2 North America Intravenous (IV) Solution Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Intravenous (IV) Solution Sales Breakdown by Company
7.1.1 Europe Intravenous (IV) Solution Sales by Company (2017-2022)
7.1.2 Europe Intravenous (IV) Solution Revenue by Company (2017-2022)
7.2 Europe Intravenous (IV) Solution Market Size by Type
7.2.1 Europe Intravenous (IV) Solution Sales by Type (2017-2028)
7.2.2 Europe Intravenous (IV) Solution Revenue by Type (2017-2028)
7.3 Europe Intravenous (IV) Solution Market Size by Application
7.3.1 Europe Intravenous (IV) Solution Sales by Application (2017-2028)
7.3.2 Europe Intravenous (IV) Solution Revenue by Application (2017-2028)
7.4 Europe Intravenous (IV) Solution Market Size by Country
7.4.1 Europe Intravenous (IV) Solution Sales by Country (2017-2028)
7.4.2 Europe Intravenous (IV) Solution Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intravenous (IV) Solution Sales Breakdown by Company
8.1.1 Asia Pacific Intravenous (IV) Solution Sales by Company (2017-2022)
8.1.2 Asia Pacific Intravenous (IV) Solution Revenue by Company (2017-2022)
8.2 Asia Pacific Intravenous (IV) Solution Market Size by Type
8.2.1 Asia Pacific Intravenous (IV) Solution Sales by Type (2017-2028)
8.2.2 Asia Pacific Intravenous (IV) Solution Revenue by Type (2017-2028)
8.3 Asia Pacific Intravenous (IV) Solution Market Size by Application
8.3.1 Asia Pacific Intravenous (IV) Solution Sales by Application (2017-2028)
8.3.2 Asia Pacific Intravenous (IV) Solution Revenue by Application (2017-2028)
8.4 Asia Pacific Intravenous (IV) Solution Market Size by Region
8.4.1 Asia Pacific Intravenous (IV) Solution Sales by Region
8.4.2 Asia Pacific Intravenous (IV) Solution Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Intravenous (IV) Solution Sales Breakdown by Company
9.1.1 Latin America Intravenous (IV) Solution Sales by Company (2017-2022)
9.1.2 Latin America Intravenous (IV) Solution Revenue by Company (2017-2022)
9.2 Latin America Intravenous (IV) Solution Market Size by Type
9.2.1 Latin America Intravenous (IV) Solution Sales by Type (2017-2028)
9.2.2 Latin America Intravenous (IV) Solution Revenue by Type (2017-2028)
9.3 Latin America Intravenous (IV) Solution Market Size by Application
9.3.1 Latin America Intravenous (IV) Solution Sales by Application (2017-2028)
9.3.2 Latin America Intravenous (IV) Solution Revenue by Application (2017-2028)
9.4 Latin America Intravenous (IV) Solution Market Size by Country
9.4.1 Latin America Intravenous (IV) Solution Sales by Country (2017-2028)
9.4.2 Latin America Intravenous (IV) Solution Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Intravenous (IV) Solution Sales Breakdown by Company
10.1.1 Middle East and Africa Intravenous (IV) Solution Sales by Company (2017-2022)
10.1.2 Middle East and Africa Intravenous (IV) Solution Revenue by Company (2017-2022)
10.2 Middle East and Africa Intravenous (IV) Solution Market Size by Type
10.2.1 Middle East and Africa Intravenous (IV) Solution Sales by Type (2017-2028)
10.2.2 Middle East and Africa Intravenous (IV) Solution Revenue by Type (2017-2028)
10.3 Middle East and Africa Intravenous (IV) Solution Market Size by Application
10.3.1 Middle East and Africa Intravenous (IV) Solution Sales by Application (2017-2028)
10.3.2 Middle East and Africa Intravenous (IV) Solution Revenue by Application (2017-2028)
10.4 Middle East and Africa Intravenous (IV) Solution Market Size by Country
10.4.1 Middle East and Africa Intravenous (IV) Solution Sales by Country (2017-2028)
10.4.2 Middle East and Africa Intravenous (IV) Solution Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 ICU Medical
11.1.1 ICU Medical Corporation Information
11.1.2 ICU Medical Overview
11.1.3 ICU Medical Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 ICU Medical Intravenous (IV) Solution Products and Services
11.1.5 ICU Medical Intravenous (IV) Solution SWOT Analysis
11.1.6 ICU Medical Recent Developments
11.2 B. Braun Melsungen
11.2.1 B. Braun Melsungen Corporation Information
11.2.2 B. Braun Melsungen Overview
11.2.3 B. Braun Melsungen Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 B. Braun Melsungen Intravenous (IV) Solution Products and Services
11.2.5 B. Braun Melsungen Intravenous (IV) Solution SWOT Analysis
11.2.6 B. Braun Melsungen Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Corporation Information
11.3.2 Fresenius Kabi Overview
11.3.3 Fresenius Kabi Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Fresenius Kabi Intravenous (IV) Solution Products and Services
11.3.5 Fresenius Kabi Intravenous (IV) Solution SWOT Analysis
11.3.6 Fresenius Kabi Recent Developments
11.4 Baxter
11.4.1 Baxter Corporation Information
11.4.2 Baxter Overview
11.4.3 Baxter Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Baxter Intravenous (IV) Solution Products and Services
11.4.5 Baxter Intravenous (IV) Solution SWOT Analysis
11.4.6 Baxter Recent Developments
11.5 Amanta Healthcare
11.5.1 Amanta Healthcare Corporation Information
11.5.2 Amanta Healthcare Overview
11.5.3 Amanta Healthcare Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Amanta Healthcare Intravenous (IV) Solution Products and Services
11.5.5 Amanta Healthcare Intravenous (IV) Solution SWOT Analysis
11.5.6 Amanta Healthcare Recent Developments
11.6 Terumo Medical
11.6.1 Terumo Medical Corporation Information
11.6.2 Terumo Medical Overview
11.6.3 Terumo Medical Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Terumo Medical Intravenous (IV) Solution Products and Services
11.6.5 Terumo Medical Intravenous (IV) Solution SWOT Analysis
11.6.6 Terumo Medical Recent Developments
11.7 Grifols
11.7.1 Grifols Corporation Information
11.7.2 Grifols Overview
11.7.3 Grifols Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Grifols Intravenous (IV) Solution Products and Services
11.7.5 Grifols Intravenous (IV) Solution SWOT Analysis
11.7.6 Grifols Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Intravenous (IV) Solution Value Chain Analysis
12.2 Intravenous (IV) Solution Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intravenous (IV) Solution Production Mode & Process
12.4 Intravenous (IV) Solution Sales and Marketing
12.4.1 Intravenous (IV) Solution Sales Channels
12.4.2 Intravenous (IV) Solution Distributors
12.5 Intravenous (IV) Solution Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Intravenous (IV) Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Total Parenteral Solution
Table 3. Major Manufacturers of Peripheral Parenteral Solution
Table 4. Global Intravenous (IV) Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Intravenous (IV) Solution Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Intravenous (IV) Solution Sales by Region (2017-2022) & (K MT)
Table 7. Global Intravenous (IV) Solution Sales Market Share by Region (2017-2022)
Table 8. Global Intravenous (IV) Solution Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Intravenous (IV) Solution Revenue Market Share by Region (2017-2022)
Table 10. Global Intravenous (IV) Solution Sales Forecast by Region (2023-2028) & (K MT)
Table 11. Global Intravenous (IV) Solution Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Intravenous (IV) Solution Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Intravenous (IV) Solution Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Intravenous (IV) Solution Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Intravenous (IV) Solution Market Trends
Table 16. Intravenous (IV) Solution Market Drivers
Table 17. Intravenous (IV) Solution Market Challenges
Table 18. Intravenous (IV) Solution Market Restraints
Table 19. Global Intravenous (IV) Solution Sales by Manufacturers (2017-2022) & (K MT)
Table 20. Global Intravenous (IV) Solution Sales Share by Manufacturers (2017-2022)
Table 21. Global Intravenous (IV) Solution Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Intravenous (IV) Solution Manufacturers by Revenue (US$ Million) in 2021
Table 23. Intravenous (IV) Solution Revenue Share by Manufacturers (2017-2022)
Table 24. Global Intravenous (IV) Solution Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous (IV) Solution as of 2021)
Table 26. Key Manufacturers Intravenous (IV) Solution Average Selling Price (ASP) & (2017-2022) & (USD/MT)
Table 27. Key Manufacturers Intravenous (IV) Solution Plants/Factories Distribution
Table 28. Key Manufacturers Intravenous (IV) Solution Area Served
Table 29. Date of Key Manufacturers Enter into Intravenous (IV) Solution Market
Table 30. Key Manufacturers Intravenous (IV) Solution Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Intravenous (IV) Solution Sales (K MT) by Type (2017-2022)
Table 33. Global Intravenous (IV) Solution Sales Share by Type (2017-2022)
Table 34. Global Intravenous (IV) Solution Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Intravenous (IV) Solution Price (K MT) by Type (2017-2022)
Table 36. Global Intravenous (IV) Solution Sales (K MT) by Type (2023-2028)
Table 37. Global Intravenous (IV) Solution Sales Share by Type (2023-2028)
Table 38. Global Intravenous (IV) Solution Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Intravenous (IV) Solution Revenue Share by Type (2023-2028)
Table 40. Global Intravenous (IV) Solution Price (K MT) by Type (2023-2028)
Table 41. Global Intravenous (IV) Solution Sales (K MT) by Application (2017-2022)
Table 42. Global Intravenous (IV) Solution Sales Share by Application (2017-2022)
Table 43. Global Intravenous (IV) Solution Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Intravenous (IV) Solution Price (K MT) by Application (2017-2022)
Table 45. Global Intravenous (IV) Solution Sales (K MT) by Application (2023-2028)
Table 46. Global Intravenous (IV) Solution Sales Share by Application (2023-2028)
Table 47. Global Intravenous (IV) Solution Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Intravenous (IV) Solution Revenue Share by Application (2023-2028)
Table 49. Global Intravenous (IV) Solution Price (K MT) by Application (2023-2028)
Table 50. North America Intravenous (IV) Solution Sales by Company (2017-2022) & (K MT)
Table 51. North America Intravenous (IV) Solution Sales Market Share by Company (2017-2022)
Table 52. North America Intravenous (IV) Solution Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Intravenous (IV) Solution Revenue Market Share by Company (2017-2022)
Table 54. North America Intravenous (IV) Solution Sales by Type (2017-2022) & (K MT)
Table 55. North America Intravenous (IV) Solution Sales by Type (2023-2028) & (K MT)
Table 56. North America Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Intravenous (IV) Solution Sales by Application (2017-2022) & (K MT)
Table 59. North America Intravenous (IV) Solution Sales by Application (2023-2028) & (K MT)
Table 60. North America Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Intravenous (IV) Solution Sales by Country (2017-2022) & (K MT)
Table 63. North America Intravenous (IV) Solution Sales by Country (2023-2028) & (K MT)
Table 64. North America Intravenous (IV) Solution Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Intravenous (IV) Solution Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Intravenous (IV) Solution Sales by Company (2017-2022) & (K MT)
Table 67. Europe Intravenous (IV) Solution Sales Market Share by Company (2017-2022)
Table 68. Europe Intravenous (IV) Solution Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Intravenous (IV) Solution Revenue Market Share by Company (2017-2022)
Table 70. Europe Intravenous (IV) Solution Sales by Type (2017-2022) & (K MT)
Table 71. Europe Intravenous (IV) Solution Sales by Type (2023-2028) & (K MT)
Table 72. Europe Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Intravenous (IV) Solution Sales by Application (2017-2022) & (K MT)
Table 75. Europe Intravenous (IV) Solution Sales by Application (2023-2028) & (K MT)
Table 76. Europe Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Intravenous (IV) Solution Sales by Country (2017-2022) & (K MT)
Table 79. Europe Intravenous (IV) Solution Sales by Country (2023-2028) & (K MT)
Table 80. Europe Intravenous (IV) Solution Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Intravenous (IV) Solution Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Intravenous (IV) Solution Sales by Company (2017-2022) & (K MT)
Table 83. Asia Pacific Intravenous (IV) Solution Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Intravenous (IV) Solution Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Intravenous (IV) Solution Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Intravenous (IV) Solution Sales by Type (2017-2022) & (K MT)
Table 87. Asia Pacific Intravenous (IV) Solution Sales by Type (2023-2028) & (K MT)
Table 88. Asia Pacific Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Intravenous (IV) Solution Sales by Application (2017-2022) & (K MT)
Table 91. Asia Pacific Intravenous (IV) Solution Sales by Application (2023-2028) & (K MT)
Table 92. Asia Pacific Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Intravenous (IV) Solution Sales by Region (2017-2022) & (K MT)
Table 95. Asia Pacific Intravenous (IV) Solution Sales by Region (2023-2028) & (K MT)
Table 96. Asia Pacific Intravenous (IV) Solution Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Intravenous (IV) Solution Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Intravenous (IV) Solution Sales by Company (2017-2022) & (K MT)
Table 99. Latin America Intravenous (IV) Solution Sales Market Share by Company (2017-2022)
Table 100. Latin America Intravenous (IV) Solution Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Intravenous (IV) Solution Revenue Market Share by Company (2017-2022)
Table 102. Latin America Intravenous (IV) Solution Sales by Type (2017-2022) & (K MT)
Table 103. Latin America Intravenous (IV) Solution Sales by Type (2023-2028) & (K MT)
Table 104. Latin America Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Intravenous (IV) Solution Sales by Application (2017-2022) & (K MT)
Table 107. Latin America Intravenous (IV) Solution Sales by Application (2023-2028) & (K MT)
Table 108. Latin America Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Intravenous (IV) Solution Sales by Country (2017-2022) & (K MT)
Table 111. Latin America Intravenous (IV) Solution Sales by Country (2023-2028) & (K MT)
Table 112. Latin America Intravenous (IV) Solution Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Intravenous (IV) Solution Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Intravenous (IV) Solution Sales by Company (2017-2022) & (K MT)
Table 115. Middle East and Africa Intravenous (IV) Solution Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Intravenous (IV) Solution Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Intravenous (IV) Solution Sales by Type (2017-2022) & (K MT)
Table 119. Middle East and Africa Intravenous (IV) Solution Sales by Type (2023-2028) & (K MT)
Table 120. Middle East and Africa Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Intravenous (IV) Solution Sales by Application (2017-2022) & (K MT)
Table 123. Middle East and Africa Intravenous (IV) Solution Sales by Application (2023-2028) & (K MT)
Table 124. Middle East and Africa Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Intravenous (IV) Solution Sales by Country (2017-2022) & (K MT)
Table 127. Middle East and Africa Intravenous (IV) Solution Sales by Country (2023-2028) & (K MT)
Table 128. Middle East and Africa Intravenous (IV) Solution Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Intravenous (IV) Solution Revenue by Country (2023-2028) & (US$ Million)
Table 130. ICU Medical Corporation Information
Table 131. ICU Medical Description and Overview
Table 132. ICU Medical Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 133. ICU Medical Intravenous (IV) Solution Product and Services
Table 134. ICU Medical Intravenous (IV) Solution SWOT Analysis
Table 135. ICU Medical Recent Developments
Table 136. B. Braun Melsungen Corporation Information
Table 137. B. Braun Melsungen Description and Overview
Table 138. B. Braun Melsungen Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 139. B. Braun Melsungen Intravenous (IV) Solution Product and Services
Table 140. B. Braun Melsungen Intravenous (IV) Solution SWOT Analysis
Table 141. B. Braun Melsungen Recent Developments
Table 142. Fresenius Kabi Corporation Information
Table 143. Fresenius Kabi Description and Overview
Table 144. Fresenius Kabi Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 145. Fresenius Kabi Intravenous (IV) Solution Product and Services
Table 146. Fresenius Kabi Intravenous (IV) Solution SWOT Analysis
Table 147. Fresenius Kabi Recent Developments
Table 148. Baxter Corporation Information
Table 149. Baxter Description and Overview
Table 150. Baxter Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 151. Baxter Intravenous (IV) Solution Product and Services
Table 152. Baxter Intravenous (IV) Solution SWOT Analysis
Table 153. Baxter Recent Developments
Table 154. Amanta Healthcare Corporation Information
Table 155. Amanta Healthcare Description and Overview
Table 156. Amanta Healthcare Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 157. Amanta Healthcare Intravenous (IV) Solution Product and Services
Table 158. Amanta Healthcare Intravenous (IV) Solution SWOT Analysis
Table 159. Amanta Healthcare Recent Developments
Table 160. Terumo Medical Corporation Information
Table 161. Terumo Medical Description and Overview
Table 162. Terumo Medical Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 163. Terumo Medical Intravenous (IV) Solution Product and Services
Table 164. Terumo Medical Intravenous (IV) Solution SWOT Analysis
Table 165. Terumo Medical Recent Developments
Table 166. Grifols Corporation Information
Table 167. Grifols Description and Overview
Table 168. Grifols Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)
Table 169. Grifols Intravenous (IV) Solution Product and Services
Table 170. Grifols Intravenous (IV) Solution SWOT Analysis
Table 171. Grifols Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Intravenous (IV) Solution Distributors List
Table 175. Intravenous (IV) Solution Customers List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous (IV) Solution Product Picture
Figure 2. Global Intravenous (IV) Solution Sales Market Share by Type in 2021 & 2028
Figure 3. Total Parenteral Solution Product Picture
Figure 4. Peripheral Parenteral Solution Product Picture
Figure 5. Global Intravenous (IV) Solution Sales Market Share by Application in 2021 & 2028
Figure 6. Hospitals & Clinics Use Case
Figure 7. Ambulatory Use Case
Figure 8. Homecare Use Case
Figure 9. Intravenous (IV) Solution Report Years Considered
Figure 10. Global Intravenous (IV) Solution Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Intravenous (IV) Solution Market Size 2017-2028 (US$ Million)
Figure 12. Global Intravenous (IV) Solution Sales (2017-2022) & (K MT)
Figure 13. Global Intravenous (IV) Solution Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Intravenous (IV) Solution Sales Market Share by Region (2017-2022)
Figure 15. Global Intravenous (IV) Solution Sales Market Share by Region in 2021
Figure 16. Global Intravenous (IV) Solution Revenue Market Share by Region in 2017 VS 2021
Figure 17. Global Intravenous (IV) Solution Sales Share by Manufacturers in 2021
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravenous (IV) Solution Sales in 2021
Figure 19. Intravenous (IV) Solution Revenue Share by Manufacturers in 2021
Figure 20. Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Intravenous (IV) Solution Revenue Share by Type (2017-2022)
Figure 22. Global Intravenous (IV) Solution Revenue Growth Rate by Type in 2017 & 2021
Figure 23. Global Intravenous (IV) Solution Revenue Share by Application (2017-2022)
Figure 24. Global Intravenous (IV) Solution Revenue Growth Rate by Application in 2017 & 2021
Figure 25. North America Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
Figure 26. North America Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)
Figure 27. North America Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
Figure 28. North America Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)
Figure 29. North America Intravenous (IV) Solution Sales Share by Country (2017-2028)
Figure 30. North America Intravenous (IV) Solution Revenue Share by Country (2017-2028)
Figure 31. U.S. Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
Figure 32. Canada Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
Figure 33. Europe Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
Figure 34. Europe Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)
Figure 35. Europe Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
Figure 36. Europe Intravenous (IV) Solution Revenue Market Sh
Write comment about above report:
Related Reports
|
Global Intravenous (IV) Solution Market Growth 2022-2028
As the global economy mends, the 2021 growth of Intravenous (IV) Solution will have significant change from previous year. According to our (LP Information) latest study, the global Intravenous (IV) Solution market size is USD million in 2022 from US... |
|
Global Sterile Intravenous (IV) Solution Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Report Scope This latest report researches the industry structure, revenue and gross margin. Major playersÂ’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access... |
|
Global Sterile Intravenous (IV) Solution Market Growth (Status and Outlook) 2019-2024
According to this study, over the next five years the Sterile Intravenous (IV) Solution market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this re... |
We are on:
Why ReportsnReports.com?
- 500,000 market research reports and growing.
- Top Fortune 500 Organizations trust us for research data.
- 24/7 support on call as well as emails.
- Your Details are safe with us.
- Free support for your research requirements.
- Report Delivery: Email
- Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays